FTSE struggles for gains after another dire warning over the economy
MarketWatch · 2天前
Declining Stock and Solid Fundamentals: Is The Market Wrong About Smith & Nephew plc (LON:SN.)?
Simply Wall St. · 2天前
Is Smith & Nephew plc (SNN) A Good Stock To Buy?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. We at Insider Monkey have plowed through 821 13F filings that hedge funds and well-known value investors are
Insider Monkey · 06/24 20:28
Smith+Nephew announces new milestone with its OXINIUM Advanced Bearing System implants surpassing two million procedures
PR Newswire · 06/18 13:00
Smith+Nephew's Regeneten Implant CE Mark'd
Seeking Alpha - Article · 06/16 11:14
Smith+Nephew's REGENETEN Bioinductive Implant Receives CE Mark
Smith+Nephew (NYSE: SNN) is pleased to announced that its REGENETEN Bioinductive Implant has successfully received CE Mark certification allowing the implant to now be used and sold in key European markets.
Benzinga · 06/16 09:30
Smith+Nephew's revolutionary REGENETEN™ Bioinductive Implant receives CE Mark
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, is pleased to announced that its REGENETEN Bioinductive Implant has successfully received CE Mark certification allowing the implant to now be used and sold in key European markets. With
Smith & Nephew plc是一家医疗技术公司。该公司开发、制造、营销和销售医疗器械并提供相关服务。其产品和服务包括运动医学关节修复、关节镜辅助技术（AET）、创伤和肢体、其他外科业务、膝关节植入物、髋关节植入物、高级伤口护理、高级伤口生物活性物质以及先进的伤口护理设备等。其运动医学关节修复特许经营业务为外科医生提供关节微创手术所需的一系列仪器、技术和植入物，包括软组织损伤修复以及膝盖、髋关节和肩部退行性病症治疗等。AET特许经营业务提供一系列微创手术系统和设备。创伤和肢体特许经营业务为医疗保健专业人员提供稳定严重骨折、矫正骨骼畸形、治疗关节炎和治疗软组织并发症的外科医生使用的解决方案。